Tadafumi Tamura* and Kenji Ohmori
Pharmaceutical Research Institute, Kyowa Hakko Kogyo Co., Ltd., Shimotogari, Nagaizumi, Sunto, Shizuoka 411-8731, Japan
*Corresponding author. FAX: +81-559-86-7430
Abstract: Diacerein has proved to be effective in the treatment of osteoarthritis. We investigated the effects of rhein, an active metabolite of diacerein, on the degradation of recombinant human interleukin-1a (rhIL-1a)-induced proteoglycan and matrix metalloproteinases (MMPs) release from rabbit articular chondrocytes. Chondrocytes were treated for 24 h with rhein in the presence of rhIL-1a. Rhein suppressed the rhIL-1a-induced proteoglycan degradation. In addition, rhein decreased the rhIL-1a-induced proMMP-3 production and reduced the MMPs activity. These results suggested that diacerein might have a protective effect on proteoglycan degradation via the suppressive effect of rhein on the production of proMMPs.
Keywords: Diacerein, Rhein, Chondroprotection
Copyright The Japanese Pharmacological Society
[Back to TOC]